Skip to content

Calcium Gluconate

Published: July 26, 2026Updated: July 26, 2026

Calcium gluconate is a mineral supplement that increases serum ionized calcium levels when administered intravenously. It is primarily used to treat hypocalcemia (low blood calcium) and to provide calcium supplementation in patients with calcium deficiency. The medication dissociates into ionized calcium and gluconate in plasma, both of which are natural constituents of body fluids.

Quick summary

A mineral supplement that treats low blood calcium by increasing ionized calcium levels through intravenous administration.

Medically reviewed by WellAlly Editorial TeamLast reviewed July 26, 2026Editorial policy

Key facts at a glance

ATC
A12AA03
RxNorm
1908
Generic
Calcium Gluconate
Class
atc-a12
Brands
Calgonate
Availability
rx
Lactation
unknown
Routes
topical, oral
Forms
injection, solution, gel, capsule, tablet
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Dosage and administration

adult (standard)tablet
Usual dose
500mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
pediatric (standard)tablet
Usual dose
250mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
geriatric (standard)tablet
Usual dose
400mg daily
Maximum
consult physician
Frequency
once daily
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard

Overdose information

Important overdose information
Toxic dose: Single dose that may cause serious toxicity including severe hypercalcemia
Chronic overdose: Prolonged excessive supplementation leading to hypercalcemia
Immediate actions
discontinue calcium administration, initiate IV fluids, monitor cardiac function and electrolytes
Antidote
No specific antidote; treat hypercalemia with bisphosphonates, calcitonin, or dialysis(Supportive treatment to lower serum calcium levels)
Poison Control: 1-800-222-1222

Special Populations

11 groups
⚠

pregnancy

first trimester
caution
FDA Category
C
Dose Adjustment

use only if clearly needed

Key Recommendations

avoid use during first trimester unless benefits clearly outweigh risks

Monitor

regular fetal monitoring and maternal calcium levels

Use with caution and monitor for adverse effects.

⚠

pregnancy

second trimester
caution
FDA Category
C
Dose Adjustment

use only if clearly needed

Key Recommendations

use only when indicated for maternal hypocalcemia treatment

Monitor

monitor maternal serum calcium and fetal development

Use with caution and monitor for adverse effects.

⚠

pregnancy

third trimester
caution
FDA Category
C
Dose Adjustment

use only if clearly needed

Key Recommendations

use for treatment of hypocalcemia when benefits outweigh risks

Monitor

close monitoring of maternal and fetal calcium levels

Use with caution and monitor for adverse effects.

✓

lactation

breastfeeding
safe
FDA Category
C
Dose Adjustment

no adjustment typically required

Key Recommendations

compatible with breastfeeding, calcium is excreted in minimal amounts in breast milk

Monitor

monitor infant for signs of hypercalcemia if high doses used

✓

pediatric_age

neonates
safe
FDA Category
C
Dose Adjustment

weight-based dosing required

Key Recommendations

neonatal hypocalcemia treatment, dosing based on weight and severity

Monitor

frequent serum calcium monitoring, ECG monitoring for arrhythmias

✓

pediatric_age

infants children
safe
FDA Category
C
Dose Adjustment

weight-based dosing required

Key Recommendations

use for treatment of hypocalcemia in pediatric patients

Monitor

regular serum calcium monitoring

⚠

geriatric

elderly
caution
FDA Category
C
Dose Adjustment

consider reduced dosing and renal function

Key Recommendations

use with caution due to age-related decline in renal function

Monitor

monitor renal function and serum calcium levels regularly

Use with caution and monitor for adverse effects.

⚠

renal_impairment

mild to moderate
caution
FDA Category
C
Dose Adjustment

dose adjustment may be required

Key Recommendations

use with caution, monitor serum calcium frequently

Monitor

frequent serum calcium, phosphorus, and renal function monitoring

Use with caution and monitor for adverse effects.

⚠

renal_impairment

severe
caution
FDA Category
C
Dose Adjustment

significant dose reduction required

Key Recommendations

use only when benefits outweigh risks, reduced dosing

Monitor

very close monitoring of serum calcium, phosphorus, and renal function

Use with caution and monitor for adverse effects.

✓

hepatic_impairment

mild to moderate
safe
FDA Category
C
Dose Adjustment

no significant adjustment typically required

Key Recommendations

generally safe in hepatic impairment

Monitor

standard monitoring of serum calcium

⚠

alcohol_users

chronic alcoholism
caution
FDA Category
C
Dose Adjustment

may require adjusted dosing

Key Recommendations

alcoholics may have calcium and vitamin D deficiency, monitor levels

Monitor

monitor serum calcium, magnesium, and vitamin D levels

Use with caution and monitor for adverse effects.

Statistics and clinical data

prescribingFDA
2023

Commonly prescribed since

Value:1950s

General prescribing information

drug_classWHO
2023

Drug class

Value:Electrolyte supplement

Drug class information

usageMedical guidelines
2023

Common uses

Value:Treatment of hypocalcemia, calcium deficiency, cardiac calcium channel blocker toxicity

Common therapeutic uses

mechanismPharmacology references
2023

Mechanism of action

Value:Provides calcium ions to restore normal neuromuscular function

Mechanism of action information

Treatment and prevention of hypocalcemia (low blood calcium), calcium deficiency, tetany, and as an adjunct in the management of hypermagnesemia. May also be used in cardiac resuscitation and as an antidote for calcium channel blocker or beta-blocker toxicity.

Intravenous administration delivers calcium gluconate directly into the bloodstream, where it dissociates into ionized calcium and gluconate. Ionized calcium is the physiologically active form that participates in essential bodily functions including nerve conduction, muscle contraction, blood coagulation, and cellular processes.

Must be administered intravenously by healthcare professionals. Rapid injection may cause hypotension, bradycardia, or cardiac arrhythmias. Caution required in patients taking digitalis glycosides. Monitor serum calcium levels during treatment. May cause irritation at the injection site.

Contraindications

Conditions and patient states where this medication should be avoided or used with caution.

Do not use (1)

ABSOLUTEhypersensitivity

Known allergy to this medication or its components

Use caution (1)

RELATIVEpregnancy

Consult healthcare provider for benefits vs risks assessment

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed July 26, 2026. · Read our editorial policy